CoreWeave counsel sells 97,500 shares under plan

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) reported that its General Counsel and Secretary, Kristen J. McVeety, exercised stock options for 97,500 shares of Class A Common Stock at an exercise price of $0.55 per share on September 8, 2026, then sold 97,500 shares in market transactions at weighted average prices around $93–$95. These transactions were made under a Rule 10b5-1 trading plan adopted on May 13, 2026, and she continued to hold 579,707 stock options directly after the exercise, with the option series expiring on April 20, 2032.

Insider Trade Summary 10b5-1

Exercise and Sale: 97,500 shares ($9.11M approx. pre-tax spread)

Exercise and Sale 4 txns

Insider McVeety Kristen J

Role GC and Secretary

Sold 97,500 shs ($9.16M)

Approx. gross sale proceeds $9.16M

Approx. exercise cost $54K

Approx. pre-tax spread $9.11M

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F1, F4	97,500	$0.00	$0.00
Exercise	Class A Common Stock F1	97,500	$0.55	$54K
Sale	Class A Common Stock F1, F2	55,945	$93.5362	$5.23M
Sale	Class A Common Stock F1, F3	41,555	$94.4744	$3.93M

Holdings After Transaction: Stock Option (Right to Buy) — 579,707 contracts (Direct); Class A Common Stock — 123,313 shares (Direct)

Footnotes (4)

1. F1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2026
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.14 to $94.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.
3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.14 to $94.76, inclusive.
4. F4. The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 1, 2025.

Key Figures

Options exercised: 97,500 shares Option exercise price: $0.55 per share Shares sold at $93.5362: 55,945 shares +5 more

8 metrics

Options exercised 97,500 shares Stock options for Class A Common Stock exercised on September 8, 2026

Option exercise price $0.55 per share Exercise price for 97,500 stock options converted into Class A Common Stock

Shares sold at $93.5362 55,945 shares Sold at weighted average price of $93.5362, in a range of $93.14–$94.13, on September 8, 2026

Shares sold at $94.4744 41,555 shares Sold at weighted average price of $94.4744, in a range of $94.14–$94.76, on September 8, 2026

Total shares sold 97,500 shares Combined Class A Common Stock sales on September 8, 2026

Remaining stock options 579,707 options Directly held stock options following the reported option exercise

Option expiration date April 20, 2032 Expiration date of the stock option award that was exercised

10b5-1 plan adoption date May 13, 2026 Date Kristen J. McVeety adopted the Rule 10b5-1 trading plan used for these trades

Key Terms

Rule 10b5-1 trading plan, weighted average price, Class A Common Stock, stock option

4 terms

Rule 10b5-1 trading plan regulatory

"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Class A Common Stock financial

"underlying security title Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

stock option financial

"The option is fully vested. Pursuant to the terms of the reporting person's award"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

FAQ

What did CoreWeave (CRWV) insider Kristen J. McVeety report on this Form 4?

She reported exercising 97,500 stock options for Class A Common Stock at an exercise price of $0.55 per share on September 8, 2026, and selling 97,500 shares of Class A Common Stock in market transactions on the same date.

At what prices were the CRWV shares sold in Kristen McVeety’s September 8, 2026 transactions?

She sold 55,945 shares at a weighted average price of $93.5362 per share, in trades ranging from $93.14 to $94.13, and 41,555 shares at a weighted average price of $94.4744, in trades ranging from $94.14 to $94.76.

Were Kristen McVeety’s CRWV transactions made under a Rule 10b5-1 trading plan?

Yes. The filing states the transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Kristen J. McVeety on May 13, 2026, indicating the trades were pre-arranged under that plan.

How many CoreWeave options does Kristen McVeety hold after the reported exercise?

After exercising 97,500 stock options, Kristen J. McVeety held 579,707 stock options of CoreWeave directly, according to the post-transaction holdings reported for that option award.

What are the vesting status and expiration date of the exercised CoreWeave options?

The stock option exercised for 97,500 shares was fully vested, with vesting completed on March 1, 2025. The option award has an expiration date of April 20, 2032, as disclosed in the filing.

What is the exercise price of the CoreWeave options exercised by Kristen McVeety?

The options that Kristen J. McVeety exercised on September 8, 2026 cover 97,500 shares of Class A Common Stock at an exercise price of $0.55 per share, as stated for the stock option award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 07:21 PM Accepted by SEC EDGAR 09/10/2026 - 07:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McVeety Kristen J

(Last) (First) (Middle)

C/O COREWEAVE, INC.

290 WEST MT. PLEASANT AVENUE, SUITE 4100

(Street)

LIVINGSTON NEW JERSEY 07039

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CoreWeave, Inc. [ CRWV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GC and Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/08/2026		M(1)		97,500	A	$0.55	220,813	D
Class A Common Stock	09/08/2026		S(1)		55,945	D	$93.5362(2)	164,868	D
Class A Common Stock	09/08/2026		S(1)		41,555	D	$94.4744(3)	123,313	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.55	09/08/2026		M(1)			97,500	(4)	04/20/2032	Class A Common Stock	97,500	$0	579,707	D

Explanation of Responses:

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2026

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.14 to $94.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.14 to $94.76, inclusive.

4. The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 1, 2025.

	/s/ Nisha Antony, as Attorney-in-Fact	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)